Reading RXO? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track RXO free→Reading RXO? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track RXO free→NYSEIndustrialsTruckingSnapshot 2026-06-12
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
Recent financial performance is weak, and the company was unprofitable over the past year, so its earnings quality can't be assessed. Risk is high, and the sector backdrop is a headwind, with RXO trading below typical levels compared to sector peers. Peer multiples imply a price about 54% above where it trades (it looks cheap on this basis); the read is cheap, value-trap risk, as it trades below peer multiples, but recent financials are weak. If RXO cuts guidance on the next call, that's a meaningful negative. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 1 valuation methods, at three horizons. Current price $28.35. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $28 RXO trades at 1× p/s, below its 2× p/s peer median. Our $69 fair value sits above the price; low confidence. Analysts: $18–$26. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price sits about 59% below a flat-multiple fair value; not enough history to forecast a comparison. This describes what's priced in, not a forecast of the move.
TTM earnings are negative, so the read leans on sales- and cash-flow-based methods rather than P/E. This is a data condition, not a forward call.
No fragility gates fired.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Industrials names rated weak grew net income 58% of the time over the next year (vs 62% for the rest of the cohort, n=3678).
Over the trailing year it converted -0.44x of net income into operating cash flow.
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, Fed net liquidity, real (inflation-adjusted) rates, long-term interest rates.
Not enough signal yet.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $0.02 → $0.02 (+2.7% / 30d). 14 raised, 0 cut, 18 covering analysts.
1 upgrade, 0 downgrades / 30d, 0 maintained. 26% of analysts rate Buy.
1 PT revisions / 30d. Avg target 25.6% above current price.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$241.
How much price usually moves either way.
On a bad day, this stock has moved -$616.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $4,307.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
Company momentum rose by 31.7 points (from -69.4 to -37.7).
No material changes since the prior snapshot.
as of 2026-06-12
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Positive cash flow shows RXO is managing money better. This is important for stability.
Confirms:Cash flow from operations turns positive in Q2, exceeding $0.
Disproves:Cash flow from operations is still negative in Q2. This hurts financial health.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for RXO yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Results of Operations and Financial Condition. On May 7, 2026, RXO, Inc. (the “Company”) issued a press release announcing its results of operations for the fiscal quarter ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
$18.00 – $26.00 (median $22.00) · 7 analysts · as of 2026-05-15
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Cargo Ground Transportation.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
RXO RXO, Inc. | Below typical Show detailsSector percentile: 6 of 100 | inexpensive | high |
ODFL Old Dominion | Typical Show detailsSector percentile: 55 of 100 | expensive | moderate |
JBHT J.B. Hunt | Typical Show detailsSector percentile: 50 of 100 | full | moderate |
XPO XPO, Inc. | Typical Show detailsSector percentile: 51 of 100 | expensive | moderate |
KNX Knight-Swift | Below typical Show detailsSector percentile: 27 of 100 | expensive | moderate |
Not investment advice. As of 2026-06-12.
via XLI
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-12.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Focus on enhancing operating income through cost management and revenue growth.
Drive revenue growth through strategic initiatives and market expansion.
Improve cash flow from operations through better cost management and efficiency.
Why it matters: Better revenue growth shows RXO is doing a good job. This is important for recovery.
Confirms:Q2 revenue growth exceeds $1.43B, showing improvement from Q1.
Disproves:Q2 revenue growth is still below $1.43B. This shows RXO is still struggling.
Why it matters: Higher profit per load shows RXO is better at pricing and efficiency. This can help profits.
Confirms:Gross profit per load reported to increase sequentially in the second quarter.
Disproves:Gross profit per load reported to decrease or remain flat sequentially.
Why it matters: An increase in operating income would show RXO is managing costs better. This is crucial for long-term health.
Confirms:Operating income improves from -$28M in Q1 to better than -$20M in Q2.
Disproves:Operating income worsens beyond -$28M in Q2, showing deeper issues.
Why it matters: Flat volume shows RXO is stabilizing after past declines. Growth would mean recovery.
Confirms one read:Full truckload volume is flat or growing compared to last year.
Confirms the other:Full truckload volume is down compared to last year.
Why it matters: A growing sales pipeline indicates RXO's potential for future revenue growth. It shows market demand for their services.
Confirms:Late-stage sales pipeline is said to grow by over $200 million.
Disproves:Late-stage sales pipeline is said to decrease or grow less than $200 million.